中国糖尿病杂志
中國糖尿病雜誌
중국당뇨병잡지
CHINESE JOURNAL OF DIABETES
2015年
2期
178-181
,共4页
二甲双胍%联合治疗%降糖药物%疗效
二甲雙胍%聯閤治療%降糖藥物%療效
이갑쌍고%연합치료%강당약물%료효
Metformin%Combination therapy%Hypoglycemic agent%Efficacy
二甲双胍作为T2DM 患者的一线用药已被广泛共识,但T2DM是一种进行性疾病,起始采用二甲双胍单药治疗的患者,随时间的推移和病程的进展,常需联合其他口服降糖药物,如磺脲类、格列奈类、TZDs、α‐葡萄糖苷酶抑制剂(AGDI)、二肽基肽酶‐4(DPP‐4)抑制剂、胰升血糖素样肽‐1(GLP‐1)受体激动剂或胰岛素制剂来控制血糖。本文就二甲双胍与其他降糖药物联用的临床疗效研究进展作一综述。
二甲雙胍作為T2DM 患者的一線用藥已被廣汎共識,但T2DM是一種進行性疾病,起始採用二甲雙胍單藥治療的患者,隨時間的推移和病程的進展,常需聯閤其他口服降糖藥物,如磺脲類、格列奈類、TZDs、α‐葡萄糖苷酶抑製劑(AGDI)、二肽基肽酶‐4(DPP‐4)抑製劑、胰升血糖素樣肽‐1(GLP‐1)受體激動劑或胰島素製劑來控製血糖。本文就二甲雙胍與其他降糖藥物聯用的臨床療效研究進展作一綜述。
이갑쌍고작위T2DM 환자적일선용약이피엄범공식,단T2DM시일충진행성질병,기시채용이갑쌍고단약치료적환자,수시간적추이화병정적진전,상수연합기타구복강당약물,여광뇨류、격렬내류、TZDs、α‐포도당감매억제제(AGDI)、이태기태매‐4(DPP‐4)억제제、이승혈당소양태‐1(GLP‐1)수체격동제혹이도소제제래공제혈당。본문취이갑쌍고여기타강당약물련용적림상료효연구진전작일종술。
Metformin was widely recommended as a first‐line drug for patients with type 2 diabetes mellitus(T2DM ). However ,studies have shown that patients who start metformin as monotherapy often required additional agents to maintain glycaemic control with the natural progression of T 2DM. Anti‐diabetic agents may be used in combination with metformin ,including sulfonylureas ,glinides , thiazolidinediones(TZDs) ,α‐glucosidase inhibitor (AGDI) ,dipeptidyl peptidase‐4 inhibitor (DPP‐4) and glucagon‐like peptide‐1 (GLP‐1 ) or insulin. This paper mainly reviews the recent studies about the therapeutic effect of metformin in combination with other anti‐diabetic agents.